Meetings with the Office of Orphan Products Development: Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Administrative / Procedural, Pediatric Product Development
Published
July 9, 2015
Last updated
April 11, 2024
Description
This document provides guidance for industry, researchers, patient groups, and FDA staff on meetings with the Office of Orphan Products Development.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)